Therefore, kallistatin protects against sepsis-induced inflammation, organ damage and mortality by antagonizing TNF-α- and HMGB1-mediated inflammatory gene expression, and by inducing SOCS3 synthesis (Figure 8). Here, HMGB1 is linked to Sepsis.